# Phase I/II Study of the Src Inhibitor Dasatinib in Combination With Erlotinib in Advanced Non–Small-Cell Lung Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-i-ii-study-of-the-src-inhibitor-dasatinib-in-combination-with-erlotinib-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Eric B. Haura,Tawee Tanvetyanon,Alberto Chiappori,Charles C. Williams,George R. Simon,Scott Antonia,Jhanelle E. Gray,Sharon Litschauer,Leticia Tetteh,Anthony Neuger,Lanxi Song,Bhupendra Rawal,Michael J. Schell,Gerold Bepler |
| Citations | 195 |
| DOI | 10.1200/jco.2009.25.4029 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2009.25.4029?role=tab |
| OpenAlex ID | https://openalex.org/W2114255370 |
| PMID | 20142592 |
| Type | article |
| Year | 2010 |

## Paper authors

- [Eric B. Haura](https://scholariq.org/researchers/eric-b-haura/)
- [Tawee Tanvetyanon](https://scholariq.org/researchers/tawee-tanvetyanon/)
- [Jhanelle E. Gray](https://scholariq.org/researchers/jhanelle-e-gray/)
- [Alberto Chiappori](https://scholariq.org/researchers/alberto-chiappori/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Fibroblast Growth Factor Research](https://scholariq.org/topics/fibroblast-growth-factor-research/)
- [Cytokine Signaling Pathways and Interactions](https://scholariq.org/topics/cytokine-signaling-pathways-and-interactions/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.